Anheuser-Busch InBev, Tilray Plan CBD-Infused Drinks Via Joint Venture - Anheuser-Busch InBev (NYSE:BUD),

Tilray Inc (NASDAQ:TLRY) and Anheuser-Busch InBev NV (NYSE:BUD) announced the next step in their partnership on Thursday.

What Happened

Fluent Beverage Company, a joint venture between both companies, said it plans to commercialize non-alcoholic, CBD-infused beverages in Canada.

"Leading Fluent in my return to Canada has been very exciting. To be Fluent means to have mastery of a subject or skill. We have assembled a team with best-in-class expertise from the beverage and cannabis industries and together we are reaching higher for our consumers, with a shared commitment to setting the standard for product quality and responsible marketing," Fluent CEO Jorn Socquet said in a statement.

"We look forward to building the future of CBD-infused beverages at Fluent."

Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.

Why It Matters

Fluent Beverages' announcement is a major step in the proliferation of CBD-infused beverages on a bigger scale.

Anheuser-Busch InBev said it will participate in the partnership through its subsidiary Labatt Breweries of Canada.

What's Next

The companies said they could market CBD-infused beverages as soon as December, contingent upon Candian regulations.

Tilray Shares Jump On The Back Of Novartis Partnership

BUDAnheuser-Busch InBev SA/NV

$79.12-0.62%

Overview

TLRYTilray Brands Inc

$4.41-0.23%

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.